Vanda Pharmaceuticals Announces Participation in the J.P. Morgan Healthcare Conference

Rhea-AI Summary

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) will participate in the J.P. Morgan Healthcare Conference in San Francisco on January 12, 2023. The corporate presentation is scheduled for 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time) and will be accessible live on Vanda's corporate website. Investors are advised to log in early for registration and software setup. An archived link of the presentation will be available for 30 days post-event. Vanda focuses on developing innovative therapies to meet high unmet medical needs.

WASHINGTON, Jan. 6, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the J.P. Morgan Healthcare Conference in San Francisco, California on Thursday, January 12, 2023.  A corporate presentation is scheduled for 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time).

The corporate presentation given at the J.P. Morgan Healthcare Conference may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer 
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com 

 

View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jp-morgan-healthcare-conference-301715460.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

When will Vanda Pharmaceuticals participate in the J.P. Morgan Healthcare Conference?

Vanda Pharmaceuticals will participate in the J.P. Morgan Healthcare Conference on January 12, 2023.

What time is Vanda's presentation at the J.P. Morgan Healthcare Conference?

Vanda's corporate presentation is scheduled for 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time).

How can I access Vanda Pharmaceuticals' presentation at the conference?

The presentation can be accessed live on Vanda's corporate website under the Investors tab.

Will there be an archived version of Vanda's presentation available?

Yes, an archived link to the presentation will be available on Vanda's website for approximately 30 days after the event.

What is the focus of Vanda Pharmaceuticals?

Vanda Pharmaceuticals focuses on the development and commercialization of innovative therapies to address high unmet medical needs.